The presence of Covid-19 would sometimes have been observed in the brain of some patients. However, as reported by our colleagues from New Scientist, “the ACE2 receptor, which the virus normally uses to enter cells, is barely detectable in the brain, unlike the cells lining the nose, mouth and lungs.” The researchers therefore sought to find out how SARS-CoV-2 managed to migrate to the brain.
A team ofPastor Institute maybe have some clues to answer this question. According to one studyedited by Chiara Zurzolo and published on Wednesday in the journal Science Advancesthe virus would build tiny tunnels through which it might easily pass from the nose to the brain.
A drug to block this process
To do this, the scientists placed human brain cells and cells lining the nose in particular. While brain cells, lacking ACE2 receptors, should not have been infectedthe scientists found, following incubation, that they had indeed been.
By observing the cells nose, using an electron microscope, they then discovered that the viruses had stimulated them “to develop tiny tubes, called nanotubes, which formed connections with brain cells”. This is how SARS-CoV-2 would travel to the brain.
So far, these tiny tunnels have only been observed in the laboratory. But if it turns out that the virus does circulate in this way inside the human brain, this discovery might lead to the development of a drug to block this process. “At the moment, we do not have a specific molecule blocking the nanotubes, but we are screening to find one”, announced Chiara Zurzolo.
